Potassium lactate
Highest phase reached
Approved
Drug type
Small molecule
First approval year
1986
- First approval year
- 1986
- Listing at source
- Listed
- Highest phase reached
- Approved
- Drug type
- Small molecule
- Drug name
- Potassium lactate
- Molecular weight
- 128.17
- Structure (SMILES)
- CC(O)C(=O)[O-].[K+]
- e 326
- E-326
- e326
- E326
- ins 326
- ins no 326
- INS NO.326
- INS-326
- lactic acid monopotassium salt
- lactic acid potassium salt
- Lactic acid, monopotassium salt
- LACTIC ACID, MONOPOTASSIUM SALT, (±)-
- Lactic acid, potassium salt
- monopotassium 2 hydroxypropanoate
- Monopotassium 2-hydroxypropanoate
- monopotassium lactate
- Monopotassium lactate
- potassium 2 hydroxypropanoate
- Potassium 2-hydroxypropanoate
- potassium dl lactate
- POTASSIUM DL-LACTATE
- potassium lactate
- Potassium lactate
- Potassium lactate (solution)
- potassium lactate dl
And 7 more, listed on the interactive page.
- ATC classification codes
- B05XA15
Sources for recorded values
- CAS registry numbers
- 996-31-6
- ChEMBL ID
- CHEMBL1200664
- InChIKey
- PHZLMBHDXVLRIX-UHFFFAOYSA-M
- PubChem compound IDs
- 23671663
- FDA ingredient codes (UNII)
- 276897E67U
- 314797
- 2571989
- Applicant
- HOSPIRA
- Approval date
- 8 May 1986
- Application number
- NDA019514
- First in class
- No
- Orphan designation
- No
- Availability
- discontinued
Administration routes
- Parenteral
- Route
- Intravenous
- How often
- Based on patient's condition
- Discard unused portion
- Do not administer Lactated Ringer’s Injection unless the solution is clear and the container and seals are intact
- Use promptly after opening the container
- Prodrug
- No
- Chirality
- Achiral
- Inorganic
- No
- Heavy atoms
- 7
- Molecular formula
- C3H5KO3
- Monoisotopic mass
- 127.98757550
- Natural product
- Yes
- Recorded assays
- 26
- Active assays
- 0
Related records
Trials (353)
- "Pi" and Hot Flushes
- 0.5M Na Lactate Solution in Acute Heart Failure (AHF)
- A 21-Day Topical Safety Study of Diltiazem Hydrochloride Using a Cumulative Irritant Patch Test Design
- A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Profile of TRD303 for Postoperative Analgesia After Abdominal Surgery in China.
- A Clinical Trial to Assess Safety and Pharmacokinetics of Fosnetupitant 235 mg and Metabolites in Healthy Volunteers
- A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
- A Comparative Effectiveness Randomised Placebo Controlled Pilot Trial of the Management of Acute Lumbar Radicular Pain
- A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203)
- A Comparison of Crystalloid Alone Versus Crystalloid Plus Colloid in Shock Resuscitation
- A Comparison of Tumescence in Breast Reduction Surgery
- A First-in-Human Multi-Part Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558
- A Novel Catheter Lock Solution for Treatment of Tunneled Hemodialysis Catheter-Associated Bacteremia
- A Pharmacokinetic Study to Evaluate the Bioequivalence of a Test Formulation Compared to an Equivalent Dose of a Reference Drug Product
- A Phase 1 Study of FZ008-145 in Healthy Subjects.
- A Phase 3 Clinical Trial to Compare RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degeneration
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease
- A Phase I, Dose Escalation Study of BNC101 in Patients With Metastatic Colorectal Cancer.
- A Phase I, Randomized, Single-Blind, Four-Period Cross-Over, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Single Oral Doses of GR181413A/AT1001 in Healthy Japanese Subjects
- A Phase I/II Clinical Trial on the Per-operative Intratumoral Administration of Myeloid Dendritic Cells Plus Ipilimumab and Nivolumab, Followed by Repeated Intracavitary Plus Intravenous Administration of Nivolumab in Patients With Recurrent Glioblastoma.
- A Phase II Clinical Study of Lidocain Pertubation as Treatment for Couples With Unexplained Infertility